Safety of Eptifibatide for Subcortical Stroke Progression

BACKGROUND: There is no proven treatment for stroke progression in patients with subcortical infarcts. Eptifibatide, a glycoprotein IIb/IIIa inhibitor, might halt stroke progression by improving flow in the microcirculation. METHODS: We conducted a retrospective analysis of patients with subcortical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Martin-Schild, Sheryl, Shaltoni, Hashem, Abraham, Anitha T., Barreto, Andrew D., Hallevi, Hen, Gonzales, Nicole R., Grotta, James C., Savitz, Sean I.
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2009
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914354/
https://ncbi.nlm.nih.gov/pubmed/19844100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000247604
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky